MedTrace Logo

New Biomarkers for Predicting Systemic Complications in Obesity

NCT07260487 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 332

Last updated 2025-12-03

No results posted yet for this study

Summary

This observational cross-sectional study classified participants into obesity classes (Class I: BMI 30.0-34.9, Class II: 35.0-39.9, Class III: ≥40.0 kg/m²) based on WHO criteria. Anthropometric and biochemical measurements were used to calculate a wide range of obesity-related and cardiometabolic risk indices. The aim was to analyze whether these indices could effectively predict the presence of Metabolic Syndrome (MetS), as defined by the NCEP-ATP III criteria.

Conditions

Sponsors & Collaborators

  • Tokat Gaziosmanpasa University

    lead OTHER

Principal Investigators

  • Elif A Özşahin Delibaş, Asst. Prof. · Tokat Gaziosmanpaşa University, Faculty of Health Sciences, Department of Nutrition and Dietetics

  • Emre Y Kuyucu, Lecturer · Tokat Gaziosmanpaşa Üniversity, Faculty of Medicine, Department of Biostatistics

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2025-05-30
Completion
2025-08-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07260487 on ClinicalTrials.gov